Moore Paul Andrew (CIK 1938192) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-12). Recent activity: Buy ZYME (17,666 shares), Sell ZYME (9,560 shares), Buy ZYME (17,168 shares), Sell ZYME (9,289 shares), Buy ZYME (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-12 | Zymeworks Inc. (ZYME) | Chief Scientific Officer | Buy | 17,666 | $0 |
| 2026-01-12 | Zymeworks Inc. (ZYME) | Chief Scientific Officer | Sell | 9,560 | $216,725 |
| 2026-01-05 | Zymeworks Inc. (ZYME) | Chief Scientific Officer | Buy | 17,168 | $0 |
| 2026-01-05 | Zymeworks Inc. (ZYME) | Chief Scientific Officer | Sell | 9,289 | $233,154 |
| 2026-01-05 | Zymeworks Inc. (ZYME) | Chief Scientific Officer | Buy | 20,000 | $0 |
| 2026-01-05 | Zymeworks Inc. (ZYME) | Chief Scientific Officer | Sell | 10,821 | $271,607 |
Source: SEC Form 4 filings · as of 2026-01-12